|
HSPA5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.76519909800277E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.46679995611288E-09 |
| Normal-vs-Stage2 |
6.800800E-04 |
| Normal-vs-Stage3 |
9.99200722162641E-16 |
| Normal-vs-Stage4 |
1.60510005287051E-09 |
| Stage1-vs-Stage2 |
1.664430E-01 |
| Stage1-vs-Stage3 |
4.362100E-04 |
| Stage1-vs-Stage4 |
3.437900E-02 |
| Stage2-vs-Stage3 |
1.778020E-04 |
| Stage2-vs-Stage4 |
7.419400E-03 |
| Stage3-vs-Stage4 |
8.584000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44089209850063E-16 |
| Normal-vs-AfricanAmerican |
1.235120E-04 |
| Normal-vs-Asian |
1.57709999948352E-07 |
| Caucasian-vs-AfricanAmerican |
6.235400E-01 |
| Caucasian-vs-Asian |
2.656000E-01 |
| AfricanAmerican-vs-Asian |
9.096000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.26690016652742E-10 |
| Normal-vs-Female |
1.00010000281259E-10 |
| Male-vs-Female |
9.287600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.60449999953016E-07 |
| Normal-vs-Age(41-60Yrs) |
2.20360396596675E-11 |
| Normal-vs-Age(61-80Yrs) |
1.20170540185427E-11 |
| Normal-vs-Age(81-100Yrs) |
1.349190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.182600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.059560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.054000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.839600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.240800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.357200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.99720273442017E-12 |
| Classical-VS-Follicular |
1.28870000004611E-06 |
| Classical-VS-Other |
9.867600E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
1.64201985342061E-12 |
| Tall-VS-Other |
1.205970E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.401240E-01 |
| Follicular-VS-Normal |
1.070210E-01 |
| Other-VS-Normal |
2.175500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.06230000024499E-07 |
| Normal-vs-N1 |
1.63402624764331E-12 |
| N0-vs-N1 |
1.57030000003111E-06 |
|
|
